Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 4 Breast 4 Thoracic 2 Plasma cell 2 Other hematologic neoplasm 2 Genitourinary 2 Gastrointestinal 2 Sarcoma 1 Other solid neoplasm 1 Myeloid 1 Head & Neck 1 Gynecologic 1

Conditions

Head and Neck Neoplasms 1 Frailty 1

Interventions

pembrolizumab 180 Cisplatin 157 Radiotherapy 78 Carboplatin 71 Radiotherapy, Intensity-Modulated 69 Cetuximab 66 Magnetic Resonance Spectroscopy 64 Nivolumab 63 Paclitaxel 52 Docetaxel 50 Specimen Handling 45 Radiation 35 Gemcitabine 33 Fluorouracil 31 Surveys and Questionnaires 28 Biopsy 27 toripalimab 26 Drug Therapy 26 Platinum 25 Surgical Procedures, Operative 24 Standard of Care 23 1,2-diaminocyclohexaneplatinum II citrate 23 cemiplimab 22 atezolizumab 21 Capecitabine 20 Ipilimumab 19 Chemoradiotherapy 19 durvalumab 18 Taxes 17 Immune Checkpoint Inhibitors 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Geriatric Assessment × Head & Neck × 1 year × Clear all

NCT06638216 2025-08-28

PRE-KOVERI

Charite University, Berlin, Germany

Phase NA Completed

Frailty, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡